Viatris Inc. (VTRS) stock analysis
VTRS · Viatris Inc.
Latest recorded price: USD 20.74
Model-estimated fair value: USD 8.96. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
At $20.74, VTRS trades 131.4% above the model's base-case value of $8.96. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $4.96 in the conservative case and $13.45 in the optimistic case, with a valuation confidence score of 45/100. About 70% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -4.2%, free cash flow margin 13.5%, ROIC -8.0%. The model flags 2 risk signals for this company (1 high severity).